key: cord-0258923-e14qg975 authors: Eden, J.-S.; Sikazwe, C.; Xie, R.; Deng, Y.-M.; Sullivan, S. G.; Michie, A.; Levy, A.; Cutmore, E.; Blyth, C. C.; Britton, P. N.; Crawford, N.; Dong, X.; Dwyer, D. E.; Edwards, K. M.; Horsburgh, B. A.; Foley, D.; Kennedy, K.; Minney-Smith, C.; Speers, D.; Tulloch, R. L.; Holmes, E. C.; Dhanasekaran, V.; Smith, D. W.; Kok, J.; Barr, I. G. title: Off-season RSV epidemics in Australia after easing of COVID-19 restrictions date: 2021-07-24 journal: nan DOI: 10.1101/2021.07.21.21260810 sha: e6f009b323d4d421000fe32f8e6c36ae0e8ae682 doc_id: 258923 cord_uid: e14qg975 Human respiratory syncytial virus (RSV) is an important cause of acute respiratory infection (ARI) with the most severe disease in the young and elderly. Non-pharmaceutical interventions (NPIs) and travel restrictions for controlling COVID-19 have impacted the circulation of most respiratory viruses including RSV globally, particularly in Australia, where during 2020 the normal winter epidemics were notably absent. However, in late 2020, unprecedented widespread RSV outbreaks occurred, beginning in spring, and extending into summer across two widely separated states of Australia, Western Australia (WA) and New South Wales (NSW) including the Australian Capital Territory (ACT). Genome sequencing revealed a significant reduction in RSV genetic diversity following COVID-19 emergence except for two genetically distinct RSV-A clades. These clades circulated cryptically, likely localized for several months prior to an epidemic surge in cases upon relaxation of COVID-19 control measures. The NSW/ACT clade subsequently spread to the neighbouring state of Victoria (VIC) and caused extensive outbreaks and hospitalisations in early 2021. These findings highlight the need for continued surveillance and sequencing of RSV and other respiratory viruses during and after the COVID-19 pandemic as mitigation measures introduced may result in unusual seasonality, along with larger or more severe outbreaks in the future. and travel restrictions for controlling COVID-19 have impacted the circulation of most respiratory 50 viruses including RSV globally, particularly in Australia, where during 2020 the normal winter 51 epidemics were notably absent 3-6 . However, in late 2020, unprecedented widespread RSV 52 outbreaks occurred, beginning in spring, and extending into summer across two widely separated 53 states of Australia, Western Australia (WA) and New South Wales (NSW) including the Australian 54 Capital Territory (ACT). Genome sequencing revealed a significant reduction in RSV genetic 55 diversity following COVID-19 emergence except for two genetically distinct RSV-A clades. These burden is greatest in the young, RSV is clinically significant for all age groups, as re-infection can 68 occur throughout life 8 . The elderly and immunocompromised are particularly at risk of severe 69 infection with intensive care admission and mortality rates similar to that of influenza, posing a 70 considerable threat to residents of long-term care facilities 9,10 . RSV causes seasonal epidemics in 71 both tropical and temperate regions of the world 11 . In Australia, most temperate regions experience 72 seasonal RSV outbreaks during the autumn and winter, often peaking in June-July 12 and usually 73 preceding the influenza season 13 . In the more tropical northern parts of Australia, RSV activity 74 correlates with the rainfall and humidity patterns of the rainy season from December to March 14 . 75 76 NPIs to limit the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have 77 disrupted the typical seasonality of other common respiratory pathogens in many countries 15, 16 . 78 Australia's initial SARS-CoV-2 epidemic was effectively controlled by NPIs 17 , and those same 79 restrictions also suppressed seasonal respiratory virus circulation, particularly for influenza virus 80 and RSV, as the usual winter epidemics were notably absent during 2020 3-5 . While the control 81 measures of each Australian state and territory varied in stringency and duration 18 , all occurred 82 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted July 24, 2021. ; https://doi.org/10.1101/2021.07.21.21260810 doi: medRxiv preprint 4 throughout the usual peak of RSV seasonal activity. Interestingly, the impact of NPIs was not 83 consistent across all the common respiratory viruses: rhinoviruses and, to a lesser extent, 84 adenoviruses continued to circulate in Australia during this pandemic period after an initial 85 disruption to usual circulation 5 . The suppression of influenza and RSV activity during the COVID-19 86 pandemic in the southern hemisphere was also seen in South Africa and New Zealand 19 , where 87 similarly following an initial reduction in circulation, RSV activity rebounded in late 2020 20 and early 88 2021, respectively. Marked reductions in RSV activity have also been seen in the northern 89 hemisphere since early 2020, although some European countries 21 and US states 22 have recently 90 reported out-of-season spikes in RSV activity in early-mid 2021. There has also been a dearth of 91 RSV sequences submitted to public databases since early 2020, presumably a reflection of the 92 lack of RSV circulation and a focus on SARS-CoV-2 sequencing. 93 In late 2020, severe out-of-season RSV outbreaks occurred in several Australian states and 95 territories beginning in New South Wales and the Australian Capital Territory (NSW/ACT) and 96 Western Australia (WA). This was followed by outbreaks in Victoria (VIC) throughout the summer 97 in early 2021. To understand the change in seasonal prevalence of RSV in Australia we examined 98 RSV testing data from January 2017 to March 2021, comparing the proportion positive and overall 99 testing capacity in NSW, WA, and VIC (Figures 1 & S1 ). Before 2020, RSV activity consistently 100 began during mid-autumn (April-May) and normally persisted for six months with an epidemic peak 101 in the middle of the Australian winter (middle of July, weeks 27 to 29). In contrast, RSV activity in 102 2020 occurred between six and nine months later than historically observed, and at the peak of 103 RSV activity across each state, laboratory-confirmed RSV positivity rates were considerably higher 104 than those of the previous three seasons ( Figure 1 early 2020 across all three states with laboratory test RSV positivity rates being similar to monthly 115 averages over the previous three seasons ( Figure S1 ). The introduction of COVID-19 control 116 measures preceded the rapid decline in RSV incidence in each state. Examination of sentinel 117 hospital records for bronchiolitis by ICD-10 Australian modification (AM) codes (including both 118 RSV-confirmed bronchiolitis and bronchoiolitis of unknown cause) showed a decline that mirrored 119 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted July 24, 2021. ; https://doi.org/10.1101/2021.07.21.21260810 doi: medRxiv preprint the decrease in laboratory-confirmed RSV ( Figure S1 ). The subsequent RSV epidemics in late 120 2020 and early 2021 resulted in test positivity and ICD-10 AM admission levels equivalent to or 121 exceeding the normal winter seasonal RSV activity seen in any of the previous three years. For 122 NSW, the epidemic began in September 2020 with bimodal peaks in activity in mid-November 123 (reaching 26% positivity rate) and early January (reaching 24% positivity rate) ( Figure 1 ). The dual 124 peaks likely reflect inconsistent testing over the Christmas holiday period, as the peak in 125 bronchiolitis hospitalisations in NSW occurred between late December and early January and 126 coincided with this period (Figure 1 ). Furthermore, a December 2020 peak was also observed in 127 the ACT, where 46% of tests were positive (data not shown). For WA, the RSV epidemic began in 128 late September and peaked in December at 37% positivity, with a matching peak in bronchiolitis 129 hospitalisations ( Figure S1 ). 130 Over the course of the pandemic, the stringency of COVID-19 restrictions has varied 132 across the different states and territories. In VIC, a second wave of COVID-19 from July to August 133 2020 necessitated a longer SARS-CoV-2 control period, which likely contributed to a three-month 134 delay in the onset of RSV activity relative to epidemic outbreaks in NSW/ACT and WA. RSV 135 activity in VIC began in early January 2021 and then peaked in early March that year with 48% of 136 tests positive ( Figure 1 ). In each state, the peaks in RSV activity occurred a few months after the 137 relaxation of COVID-19 restrictions ( Figure 1 ). 138 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 24, 2021. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 24, 2021. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 24, 2021. ; https://doi.org/10.1101/2021.07.21.21260810 doi: medRxiv preprint 9 To maximise spatiotemporal sampling of the RSV-A ON-1like viruses, we expanded our 190 phylogenetic analysis to all globally available RSV glycoprotein (G) sequences ( Figure 3A) , which 191 are more numerous than published whole RSV genomes. The genome-based phylogeny was 192 comprised of 1130 RSV-A ON1-like genomes (Figure 2A) , while a further 1804 sequences were 193 included in the G protein phylogenetic analysis (Figure 3) . Despite the additional sequences, the G 194 protein phylogeny found that the viruses from the 2020-2021 epidemics did not cluster with any 195 other viruses sampled nationally or internationally up to date. As such, the initial source of these 196 two novel RSV-A lineages remains undetermined ( Figure 3A-B) . Similar to the genome-scale 197 analysis, the G protein phylogeny also revealed that the genetic diversity of other ON1-like 198 lineages that co-circulated over the well-sampled period between 2016 and 2020 were absent 199 during these outbreak periods ( Figure 3B ). We also examined RSV-B diversity, and while the (Figures 2 & 3) . In contrast, the origin and early dissemination of the 215 NSW/ACT 2020 lineage was less certain. Despite the widespread occurrence of outbreaks in NSW 216 and ACT, and the relatively high genetic diversity among the sub-lineages in this outbreak ( Figure 217 2 & 3B), no precursor virus(es) of the same lineage were detected prior to the outbreak onset, 218 despite efforts to identify and sequence cases during the low activity period earlier in 2020. In 219 addition to a lack of RSV positive samples throughout the middle of 2020, our analysis was 220 hampered by an inflated evolutionary rate due to recent sampling 27 , multiple novel non-221 synonymous substitutions observed in the G protein, and a high amount of rate variation that 222 hampered reliable phylogenetic dating estimates. Therefore, we cannot rule out either hypothesis 223 that the viruses were already present in the country before the start of the COVID-19 pandemic or 224 that there were international incursions that occurred during the middle of 2020 when COVID-19 225 restrictions were in place. 226 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 24, 2021. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 24, 2021. ; https://doi.org/10.1101/2021.07.21.21260810 doi: medRxiv preprint An examination of RSV diversity in Australia before and after the implementation of COVID-235 related NPIs using whole genome sequencing has shown a major collapse in circulating lineages 236 observed prior to 2020 23,26 . This also coincided with the emergence of two distinct but 237 phylogenetically related RSV-A lineages associated with the summer outbreaks in NSW/ACT and 238 WA, respectively. Both these lineages were found to seed new outbreaks in VIC during early 2021. findings from this study exemplify the need to be prepared for the occurrence of large outbreaks of 269 RSV outside of normal seasonal periods and for health systems to be prepared to combat future 270 severe RSV outbreaks. It also raises important questions as to how the epidemiological and 271 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 24, 2021. ; https://doi.org/10.1101/2021.07.21.21260810 doi: medRxiv preprint evolutionary dynamics of RSV outbreaks might inform the re-emergence of influenza virus, which 272 is still expected, and given the smaller role children play in population-scale transmission, may 273 require re-opening of international borders to import the variants required to effectively seed new 274 local outbreaks. Nonetheless, our study highlights the power of COVID-19-related NPIs to cause 275 immense disruption in seasonal patterns of respiratory virus circulation and evolution. Furthermore, 276 this study provides a timely warning to countries emerging from pandemic restrictions that the 277 burden of disease from other respiratory pathogens that may have all but disappeared, will likely 278 rebound in the near future, possibly at unusual times and with higher magnitude of cases. 279 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted July 24, 2021. (Table S1) . Ultrafast bootstrap approximation (UFBoot) and SH-like approximate likelihood ratio test (SH-345 aLRT) was applied to estimate branch support. G gene phylogenies were estimated using RAxML 346 v.8 40 using the GTR-nucleotide substitution model, with branch support estimated by 1000 347 bootstrap replicates. 348 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted July 24, 2021. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted July 24, 2021. ; https://doi.org/10.1101/2021.07.21.21260810 doi: medRxiv preprint Respiratory syncytial 360 virus infection in elderly and high-risk adults The burden of respiratory syncytial virus infection in young children Respiratory syncytial virus-associated hospitalisations in Australia Using routine testing data 389 to understand circulation patterns of influenza A, respiratory syncytial virus and other 390 respiratory viruses in Victoria Seasonal variability of respiratory syncytial virus 392 infection in the Top End of the Northern Territory The impact of COVID-19 nonpharmaceutical interventions on the future 395 dynamics of endemic infections Decreased influenza activity during the COVID-19 pandemic-United States Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome 399 sequencing and agent-based modeling COVID-19: a chronology of state and territory government announcements (up until 402 Impact of the COVID-19 nonpharmaceutical interventions on influenza and 406 other respiratory viral infections in New Zealand Weekly respiratory pathogens surveillance report Child Adolesc Health 4, e42-e43 (2020). . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)The copyright holder for this preprint this version posted July 24, 2021. ; https://doi.org/10.1101/2021.07.21.21260810 doi: medRxiv preprint